Hainan Huluwa Pharmaceutical Group announcement, shareholder Jia Rui, who holds more than 5% of the shares, plans to reduce their shareholding through bulk trading by no more than 5.34105 million shares, not exceeding 1.34% of the total share capital of the company starting from 15 trading days after this announcement for a period of 3 months.
葫芦娃:股东中嘉瑞拟减持不超过1.34%股份
Hainan Huluwa Pharmaceutical Group: Shareholder Jia Rui plans to reduce their shareholding by no more than 1.34%.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.